explore -WSS

explore

author：focus 2025-10-01 21:09:35 - browse：65

When Prozac first entered the psychiatry scene in in the late ’80s, the profession was still Freud’s territory. Many considered taking medication to treat depression a failure. But that was all about to change, as early stewards like psychiatrist Peter Kramer refused to shy away from the new drug’s potential. These days, he says that people take for granted all of the progress that’s been made with antidepressant treatment in the past three decades.

“If you were going to be depressed any time in history and were interested in having an effective treatment, you would want to be alive now. But we’ve lost our wonderment about that,” said Kramer, the author of the groundbreaking 1993 book “Listening to Prozac.”

This week, Kramer joins me to discuss how the country’s relationship with antidepressants has changed since the publication of his book three decades ago. The conversation is based on his First Opinion, “What antidepressants are saying 30 years after the publication of ‘Listening to Prozac.’”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： The high cost of giving birth even with insurance
Next article： New oral drug delivery patch is modeled after octopus tentacles

WSS

Congress extends some pandemic preparedness programs

The biotech scorecard for Q4: 16 stock

With Roe v Wade overturned, abortion providers work to adapt

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

RSV injection headlines need to be accurate for good uptake

2023 Nobel Prize in Medicine goes to Karikó and Weissman

focus

explore

focus

At least 13 dead in Texas as scorching temps continue

One Duchenne patient's bittersweet hope for new treatment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Flu, Covid vaccination rates decline, new survey data show

George Santos makes 1st court appearance after pleading not guilty to 13 counts

IVG is promising — but it won’t replace IVF quite yet

23andMe had bad news about my health. I wish a person had delivered it

Stop Congress from blocking public access to science

BioMarin wins approval for gene therapy to treat hemophilia A

With Roe v Wade overturned, abortion providers work to adapt

focus

Stop Congress from blocking public access to science

Will an HIV vaccine ever be a reality?

Sickle cell gene therapy cures need to be accessible in Africa

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Health insurers' Q3 question: how much care are people getting?

The biotech scorecard for Q4: 16 stock

explore

hotspot

hotspot

entertainment